J.P. Morgan, one of the largest clearing service providers for listed and OTC derivatives globally, acted as clearing member in respect of initial transactions for Whard Stewart, which was on-boarded as a Registered Customer. 

The clearing of initial client transactions well ahead of the start of the clearing obligation in Europe demonstrates the advanced readiness of J.P. Morgan and its client Whard Stewart.

"We have found that clients appreciate the margin efficiencies of clearing listed and OTC in a single CCP. Eurex clearing understands the importance of client asset segregation, and their responsiveness in shaping the new service to meet market needs has been key for us in being among the first clearing members to clear client trades," said Hester Serafini, global co-head of OTC Clearing at J.P. Morgan.

Walter Womersley, COO, Whard Stewart added: "As OTC derivatives are crucial to our strategies and performance, choosing a comprehensive and efficient clearing offering in time for the clearing requirements is mission critical for our future success. EurexOTC Clear, offered through J.P. Morgan as our clearing service provider, offers comprehensive and innovative solutions to meet our demands."

"We are very pleased about the on-boarding of Whard Stewart to our client-clearing services. It is a strong affirmation of our comprehensive offering for a wide range of buy side institutions. Having one of our largest clearing members, J.P. Morgan, introducing the client confirms the substantial progress made over the last few months," said Thomas Book, member of the Eurex Executive Board responsible for clearing.

With its new service, EurexOTC Clear for IRS launched on 13 November 2012, Eurex Clearing will fully integrate the clearing and collateralization of OTC and listed derivatives in a single clearing house within one single framework. The new service, which will be further expanded in 2013, is one important element of Eurex Clearing's comprehensive roadmap in preparing for the changing regulatory environment. The roadmap includes among others an integrated cross-product service portfolio, a broad eligible collateral spectrum and Eurex Clearing Prisma, the planned portfolio risk management across listed and OTC derivatives.